GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 35501 - 35550 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
7MW3 7MW3 Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
7MW2 7MW2 Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
7MSQ 7MSQ Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD)
7MRZ 7MRZ Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment
7MPG 7MPG Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14
7MP4 7MP4 Crystal structure of Epiphyas postvittana antennal carboxylesterase 24
7MN8 7MN8 Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab
7MMO 7MMO LY-CoV1404 neutralizing antibody against SARS-CoV-2
7MMN 7MMN Crystal Structure of the Prefusion RSV F Glycoprotein bound by human antibody AM14
7MMN 7MMN Crystal Structure of the Prefusion RSV F Glycoprotein bound by human antibody AM14
7MM0 7MM0 Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
7MLZ 7MLZ Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
7MLY 7MLY Cryo-EM reveals partially and fully assembled native glycine receptors,heteromeric pentamer
7MLV 7MLV Cryo-EM reveals partially and fully assembled native glycine receptors,homomeric tetramer
7MLU 7MLU Cryo-EM reveals partially and fully assembled native glycine receptors,homomeric pentamer
7MKM 7MKM SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement)
7MKL 7MKL SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
7MJS 7MJS Single-Particle Cryo-EM Structure of Major Facilitator Superfamily Domain containing 2A in complex with LPC-18:3
7MJL 7MJL Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (focused refinement of RBD and Fab ab1) Spike glycoprotein, Fab ab1 Heavy Chain, Fab ab1 Light Chain
7MJK 7MJK Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) Spike glycoprotein, Fab ab1 Heavy Chain, Fab ab1 Light Chain
7MJJ 7MJJ Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1) Spike glycoprotein, Fab ab1 Heavy Chain, Fab ab1 Light Chain
7MJI 7MJI Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused refinement of RBD and VH ab8) Spike glycoprotein, VH ab8
7MJH 7MJH Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 Spike glycoprotein, VH ab8
7MGW 7MGW 5-HT bound serotonin transporter reconstituted in lipid nanodisc in NaCl in occluded conformation
7MFG 7MFG Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer
7MF1 7MF1 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
7MEP 7MEP BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R
7MEM 7MEM CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA
7MDW 7MDW CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105
7MDU 7MDU BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
7MDT 7MDT BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment)
7M8L 7M8L EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs
7M7W 7M7W Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
7M7B 7M7B SARS-CoV-2 Spike:Fab 3D11 complex focused refinement Spike glycoprotein, Antibody Fab 3D11 heavy chain, Antibody Fab 3D11 light chain
7M74 7M74 ATP-bound AMP-activated protein kinase
7M72 7M72 MHC-like protein complex structure
7M72 7M72 MHC-like protein complex structure
7M71 7M71 SARS-CoV-2 Spike:5A6 Fab complex I focused refinement Spike glycoprotein, Fab 5A6 heavy chain, Fab 5A6 light chain
7M6I 7M6I Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 Spike glycoprotein, BG1-24 Fab Light Chain, BG1-24 Fab Heavy Chain
7M6H 7M6H Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 Spike glycoprotein, BG7-20 Fab Heavy Chain, BG7-20 Fab Light Chain
7M6G 7M6G Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 Spike glycoprotein, BG7-15 Fab Heavy Chain, BG7-15 Fab Light Chain
7M6F 7M6F Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 Spike glycoprotein, BG1-22 Fab Heavy Chain, BG1-22 Fab Light Chain
7M6E 7M6E Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 Spike glycoprotein, BG10-19 Fab Heavy Chain, BG10-19 Fab Light Chain
7M6D 7M6D Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022
7M42 7M42 Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989
7M3I 7M3I Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab
7M3G 7M3G Asymmetric Activation of the Calcium Sensing Receptor Homodimer
7M30 7M30 Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25
7LY9 7LY9 Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer
7LY3 7LY3 Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024